Rhoen Klinikum AG
XETRA:RHK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhoen Klinikum AG
XETRA:RHK
|
DE |
|
Dolfines SA
PAR:ALDOL
|
FR |
|
P
|
Pulsenmore Ltd
TASE:PULS
|
IL |
|
T
|
TenX Keane Acquisition
NASDAQ:TENK
|
US |
|
E
|
eMagin Corp
F:EMGA
|
US |
|
Eprice SpA
MIL:EPR
|
IT |
|
Global Mediacom Tbk PT
IDX:BMTR
|
ID |
|
L
|
Lowe's Companies Inc
XBER:LWE
|
US |
|
Midi Utama Indonesia Tbk PT
IDX:MIDI
|
ID |
|
Elixir Energy Ltd
ASX:EXR
|
AU |
|
J
|
Jinhui Mining Co Ltd
SSE:603132
|
CN |
|
B
|
BG T&A Co
KOSDAQ:046310
|
KR |
|
Kyung-In Synthetic Corp
KRX:012610
|
KR |
|
Yonghui Superstores Co Ltd
SSE:601933
|
CN |
|
Ansell Ltd
ASX:ANN
|
AU |
|
Methanol Chemicals Company SJSC
SAU:2001
|
SA |
Wall Street
Price Targets
RHK Price Targets Summary
Rhoen Klinikum AG
According to Wall Street analysts, the average 1-year price target for
RHK
is 14.45 EUR
with a low forecast of 12.63 EUR and a high forecast of 16.8 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RHK's stock price target?
Price Target
14.45
EUR
According to Wall Street analysts, the average 1-year price target for
RHK
is 14.45 EUR
with a low forecast of 12.63 EUR and a high forecast of 16.8 EUR.
What is Rhoen Klinikum AG's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Rhoen Klinikum AG's revenue is
-4%.
The projected
CAGR
for the next 4 years is
6%.
What is Rhoen Klinikum AG's Operating Income forecast?
Projected CAGR
13%
For the last 13 years the
compound annual growth rate for
Rhoen Klinikum AG's operating income is
-11%.
The projected
CAGR
for the next 4 years is
13%.
What is Rhoen Klinikum AG's Net Income forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Rhoen Klinikum AG's net income is
-9%.
The projected
CAGR
for the next 4 years is
11%.
